AAA revisited: a comprehensive review of risk factors, management, and hallmarks of pathogenesis

V Kessler, J Klopf, W Eilenberg, C Neumayer… - Biomedicines, 2022 - mdpi.com
Despite declining incidence and mortality rates in many countries, the abdominal aortic
aneurysm (AAA) continues to represent a life-threatening cardiovascular condition with an …

Genetics and mechanisms of thoracic aortic disease

E Chou, JP Pirruccello, PT Ellinor… - Nature Reviews …, 2023 - nature.com
Aortic disease has many forms including aortic aneurysm and dissection, aortic coarctation
or abnormalities in aortic function, such as loss of aortic distensibility. Genetic analysis in …

Projection of global burden and risk factors for aortic aneurysm–timely warning for greater emphasis on managing blood pressure

X Huang, Z Wang, Z Shen, F Lei, YM Liu… - Annals of …, 2022 - Taylor & Francis
Rationale Aortic aneurysm (AA) is a serious condition that largely increases the risk of aortic
dissection and sudden death. Exploring the global burden of disease and changes in risk …

Angiotensin II and leukocyte trafficking: New insights for an old vascular mediator. Role of redox-signaling pathways

L Piqueras, MJ Sanz - Free Radical Biology and Medicine, 2020 - Elsevier
Inflammation and activation of the immune system are key molecular and cellular events in
the pathogenesis of cardiovascular diseases, including atherosclerosis, hypertension …

Enhanced endoplasmic reticulum and mitochondrial stress in abdominal aortic aneurysm

M Navas-Madroñal, C Rodriguez, M Kassan… - Clinical …, 2019 - portlandpress.com
Abdominal aortic aneurysm (AAA) is a degenerative vascular disease with a complex
aetiology that remains to be fully elucidated. Clinical management of AAA is limited to …

Angiotensin II Type 1 Receptor Blocker Prevents Abdominal Aortic Aneurysm Progression in Osteoprotegerin‐Deficient Mice via Upregulation of Angiotensin (1–7)

K Karasaki, H Kokubo, B Bumdelger… - Journal of the …, 2023 - Am Heart Assoc
Background Angiotensin II type 1 receptor blockers (ARBs) have been shown to limit the
growth of abdominal aortic aneurysm (AAA), but their efficacy is controversial. This study …

[HTML][HTML] The effect of diabetes on abdominal aortic aneurysm growth over 2 years

MJ Nordness, BT Baxter, J Matsumura, M Terrin… - Journal of vascular …, 2022 - Elsevier
Objective Abdominal aortic aneurysm (AAA) is a common progressive disease and a
significant cause of morbidity and mortality. Prior investigations have shown that diabetes …

AT2R (Angiotensin AT2 Receptor) Agonist, Compound 21, Prevents Abdominal Aortic Aneurysm Progression in the Rat

C Lange, M Sommerfeld, P Namsolleck, U Kintscher… - …, 2018 - Am Heart Assoc
The effects of the selective AT2R (angiotensin AT2 receptor) agonist, Compound 21 (C21),
on abdominal aortic aneurysm formation were investigated in normotensive Wistar rats …

A selective antagonist of prostaglandin E receptor subtype 4 attenuates abdominal aortic aneurysm

A Mamun, U Yokoyama, J Saito, S Ito… - Physiological …, 2018 - Wiley Online Library
Abdominal aortic aneurysm (AAA) is a progressive disease that has an increasing
prevalence with aging, but no effective pharmacological therapy to attenuate AAA …

Top 10 candidate aortic disease trials

RL Dalman, A Wanhainen, K Mani… - Journal of Internal …, 2020 - Wiley Online Library
Aortic pathologies such as aneurysm, dissection and trauma are relatively common and
potentially fatal diseases. Over the past two decades, we have experienced unprecedented …